Insider Trading March 23, 2026 05:28 PM

Thryv Director Buys $13,000 in Shares as Company Repositions Toward Higher-Value Customers

Orfanos Lou adds 5,000 common shares on March 18, 2026 amid a year of sharp share declines and mixed fourth-quarter results

By Derek Hwang THRY

Thryv Holdings director Orfanos Lou purchased 5,000 shares on March 18, 2026 at $2.60 per share, a $13,000 transaction that brings his direct holdings to 16,035 shares. The move comes after an 82% year-over-year slide in Thryv's stock, which has since traded up to $2.97, and follows a fourth-quarter 2025 earnings report that missed EPS expectations while slightly topping revenue estimates. Analysts maintain differing views on fair value with price targets in the $4 to $6 range.

Thryv Director Buys $13,000 in Shares as Company Repositions Toward Higher-Value Customers
THRY

Key Points

  • Insider purchase: Director Orfanos Lou bought 5,000 shares at $2.60 on March 18, 2026, bringing his direct ownership to 16,035 shares - relevant to investors tracking insider confidence.
  • Mixed quarterly results: Q4 2025 EPS of -$0.22 missed the $0.18 forecast by -222.22%, while revenue of $191.62 million slightly exceeded the $191.25 million estimate.
  • Strategic pivot and analyst views: Thryv is shifting toward customers with $400+ monthly revenue and launching the Market Sell Grow AI-enabled platform; analyst price targets range from $4 to $6 with differing ratings from Craig-Hallum and Needham.

Director Orfanos Lou of Thryv Holdings Inc (NASDAQ:THRY) purchased 5,000 shares of the company’s common stock on March 18, 2026, according to a filing. The shares were acquired at $2.60 each, for a total outlay of $13,000. After the transaction, Lou directly owns 16,035 shares of Thryv.

The purchase arrives after a period of steep share-price erosion: Thryv’s stock has fallen roughly 82% over the past year, although recent trading has seen the price rebound to $2.97. InvestingPro analysis cited in company materials indicates the stock may be undervalued at current levels, with analyst price targets reported in a $4 to $6 range.


Latest financials and strategic update

Thryv’s reported fourth-quarter 2025 results included an earnings-per-share (EPS) figure of -$0.22, missing the consensus forecast of $0.18. That shortfall represents a surprise of -222.22% relative to expectations. Revenue for the quarter was $191.62 million, narrowly ahead of the forecasted $191.25 million.

The company has signaled a strategic shift toward higher-value customers, concentrating on those that generate at least $400 in monthly revenue. As part of that pivot, Thryv is rolling out Market Sell Grow, an AI-enabled platform intended to support the focus on more lucrative clients.

Analysts have reacted to the results and strategic refocus with adjustments to their price targets. Craig-Hallum lowered its target to $4.00 while keeping a Hold rating. Needham reduced its price target to $6.00 but retained a Buy rating, noting that Thryv’s most recent results were broadly in line with expectations but flagging weak customer growth as a concern.


Research resources

For investors seeking additional valuation context and a deeper look at Thryv’s prospects, a Pro Research Report is available on InvestingPro for THRY and more than 1,400 other U.S. equities, according to company materials.

Risks

  • Earnings risk: The significant EPS miss in Q4 2025 highlights execution or margin pressures that could weigh on investor sentiment and affect market valuation - impacting the software and small-business services sectors.
  • Customer growth uncertainty: Needham explicitly cited weak customer growth as a concern, which could slow revenue expansion and limit the effectiveness of the company’s pivot toward higher-value customers - relevant to marketing services and SMB software markets.
  • Limited signaling from purchase size: While insider buying can be interpreted as a vote of confidence, the $13,000 transaction is relatively modest and may have limited informational value for broader market participants - relevant to equity investors and market observers.

More from Insider Trading

Edwards Lifesciences CEO Executes Multi-Million Dollar Share Sale via Pre-Set Trading Plan May 12, 2026 Covista CFO Executes $1.26 Million Stock Sale via Pre-Scheduled Trading Plan May 12, 2026 Covista Executive Executes Planned Share Sale Amidst Corporate Growth and Financial Restructuring May 12, 2026 Covista Executive Executes $1.22 Million Stock Sale Under Pre-Planned Trading Program May 12, 2026 Ameriprise Financial Director Executes Stock Sale Amid Strong Earnings Performance May 12, 2026